Comorbidity in generalized anxiety disorder: Prevalence and course after cognitive-behavioural therapy;La comorbidité dans le trouble d'anxiété généralisée: Prévalence et évolution suite à une thérapie cognitivo-comportementale

Canadian Journal of Psychiatry

Volumn 51, Issue 2, 2006, Pages 91-99

  Provencher, Martin D ^a,b   Ladouceur, Robert ^b   Dugas, Michel J ^c,d  

^a Hotel Dieu de Levis Hospital   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c Dept of Electrical and Computer Engineering   (Canada)

^d HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BEHAVIOR THERAPY; COGNITIVE THERAPY; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE COURSE; FOLLOW UP; GENERALIZED ANXIETY DISORDER; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; PANIC; PHOBIA; SOCIAL PHOBIA; STRUCTURED INTERVIEW; SYMPTOMATOLOGY;

EID: 33644499117     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674370605100205     Document Type: Article

References (47)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Third edition. Washington (DC): American Psychiatric Association; 1980.
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Third edition revised. Washington (DC): American Psychiatric Association; 1987.
3. Kessler RC, Walters EE, Wittchen H-U. Epidemiology. In: Heimberg RG, Turk CL, Mennin DS, editors. Generalized anxiety disorder: Advances in research and practice. New York (NY): Guilford; 2004, p 29-50.
4. Blazer DG, Hughes D, George LK, Swartz M, Boyer R. Generalized anxiety disorder. In: Robins LN, Regier DA, editors. Psychiatric disorders in America: The epidemiologic catchment area study. New York (NY): Free Press; 1991, p 180-203.
5. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, and others. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 1994;51:8-19.
6. Wittchen H-U, Zhao S, Kessler RC, Eaton WW. DSM-III-R generalized anxiety disorder in the national comorbidity survey. Arch Gen Psychiatry 1994;51:355-64.
7. Borkovec TD, Abel JL, Newman H. Effects of psychotherapy on comorbid conditions in generalized anxiety disorder. J Consult Clin Psychol 1995;63:479-83.
8. Brawman-Mintzer O, Lydiard RB, Emmanuel N, Payeur R, Johnson M, Roberts J, and others. Psychiatric comorbidity in patients with generalized anxiety disorder. Am J Psychiatry 1993;150:1216-8.
9. de Ruiter C, Rijken H, Garssen B, van Schaik A, Kraaimaat F. Comorbidity among the anxiety disorders. J Anxiety Disord 1989;3:57-68.
10. Goisman RM, Goldenberg I, Vasile RG, Keller MB. Comorbidity of anxiety disorders in a multicenter anxiety study. Compr Psychiatry 1996;36:303-11.
11. Sanderson WC, Di Nardo PA, Rapee RP, Barlow DH. Syndrome co-morbidity in patients diagnosed with a DSM-III-Revised anxiety disorder. J Abnorm Psychol 1990; 99:308-12.
12. Brawman-Mintzer O, Lydiard RB. Generalized anxiety disorder: Issues in epidemiology. J Clin Psychiatry 1996;57(Suppl 7):3-8.
13. Andrews G. Comorbidity in neurotic disorders: The similarities are more important than the differences. In Rapee RM, editor. Current controversies in the anxiety disorders. New York (NY): Guilford; 1996, p 3-20.
14. Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ. Major depression and generalized anxiety disorder: Same genes, (partly) different environments? Arch Gen Psychiatry 1992;49:716-22.
15. Kendler KS. Major depression and generalized anxiety disorder: Same genes, (partly) different environments - revisited. Br J Psychiatry 1996;168(Suppl 30):68-75.
16. Roy-Byrne PP, Cowley DS. Pharmacological treatments for panic disorder, generalized anxiety disorder, specific phobia, and social anxiety disorder. In Nathan PE, Gorman JM, editors. A guide to treatments that work. 2nd ed. New York (NY): Oxford University Press; 2002, p 337-65.
17. Barlow DH, Raffa SD, Cohen EM. Psychosocial treatments for panic disorders, phobias, and generalized anxiety disorder. In: Nathan PE, Gorman JM, editors. A guide to treatments that work. 2nd ed. New York (NY): Oxford University Press; 2002, p 301-35.
18. Gould RA, Otto MW, Pollack MH, Yap L. Cognitive behavioral and pharmacological treatment of generalized anxiety disorder: A preliminary meta-analysis. Behav Ther 1997;28:285-305.
19. Durham RC, Allan T, Hackett CA. On predicting improvement and relapse in generalized anxiety disorder following psychotherapy. Br J Clin Psychol 1997;36:101-19.
20. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington (DC): American Psychiatric Association; 1994.
21. Dugas MJ, Ladouceur R, Léger É, Freeston MH, Langlois F, Provencher MD, and others. Group cognitive-behavioral therapy for generalized anxiety disorder: treatment outcome and long-term follow-up. J Consult Clin Psychol 2003;71:821-5.
22. Ladouceur R, Dugas MJ, Freeston MH, Léger E, Gagnon F, Thibodeau N. Effectiveness of a new cognitive-behavioral treatment for generalized anxiety disorder: evaluation in a controlled clinical trial. J Consult Clin Psychol 2000;68:957-64.
23. Provencher MD, Dugas MJ, Ladouceur R. Efficacy of problem-solving training and cognitive exposure in the treatment of generalized anxiety disorder: a case replication series. Cognitive and Behavioral Practice 2004;11:404-14.
24. Brown TA, Di Nardo PA, Barlow DH. Anxiety Disorders Interview Schedule for DSM-IV. Albany (NY): Graywind; 1994.
25. Dugas MJ, Gagnon F, Ladouceur R, Freeston MH. Generalized Anxiety Disorder: a preliminary test of a conceptual model. Behav Res Ther 1998;36:215-26.
26. Brown TA, Di Nardo PA, Lehman CL, Campbell LA. Reliability of DSM-IV anxiety and mood disorders: implications for classification of emotional disorders. J Abnorm Psychol 2001;110:49-58.
27. Meyer TJ, Miller ML, Metzger RL, Borkovec TD. Development and validation of the Penn State Worry Questionnaire. Behav Res Ther 1990;28:487-96.
28. Gosselin P, Dugas MJ, Ladouceur R, Freeston MH. Évaluation des inquiétudes : validation d'une traduction française du Penn State Worry Questionnaire. Encephale 2001;27:475-84.
29. Dugas MJ, Freeston MH, Provencher MD, Lachance S, Ladouceur R, Gosselin P. Le questionnaire sur l'inquiétude et l'anxiété : validation dans des échantillons non cliniques et cliniques. Journal de Thérapie Comportementale et Cognitive 2001;11:31-6.
30. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988;56:893-7.
31. Freeston MH, Ladouceur R, Thibodeau N, Gagnon F, Rhéaume J. L'inventaire d'anxiété de Beck : propriétés psychométriques d'une traduction française. Encephale 1994;20:47-55.
32. Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive therapy of depression. New York (NY): Guilford; 1979.
33. Bourque P, Beaudette D. Étude psychométrique du questionnaire de dépression de Beck auprès d'un échantillon d'étudiants universitaires francophones. Revue canadienne des sciences du comportement 1982;14:211-8.
34. Jacobson NE, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 1991;59:12-9.
35. Brown TA, Barlow DH. Comorbidity among anxiety disorders: implications for treatment and DSM-IV. J Consult Clin Psychol 1992;60:835-44.
36. Barlow DH, DiNardo PA, Vermilea BB, Vermilyea J, Blanchard EB. Co-morbidity and depression among anxiety disorders: issues in diagnosis and classification. J Nerv Ment Dis 1986;174:63-72.
37. DiNardo PA, Barlow DH. Syndrome and symptoms co-morbidity in the anxiety disorders. In: Maser JD, Cloninger CR, editors. Comorbidity in anxiety and mood disorders. Washington (DC): American Psychiatric Press; 1990, p 205-30.
38. Brown TA, Antony MM, Barlow DH. Diagnostic comorbidity in panic disorder: effect on treatment outcome and course of comorbid diagnosis following treatment. J Consult Clin Psychol 1995;63:408-18.
39. Tsao JCI, Lewin M., Craske MG. The effects of cognitive-behavior therapy for panic disorder on comorbid conditions. J Anxiety Disord 1998;12:357-71.
40. Tsao JCI, Mystrowski JL, Zucker BG, Craske MG. Effects of cognitive-behavioral therapy for panic disorder on comorbid conditions: replication and extension. Behav Ther 2002;33:493-509.
41. Barlow DH. Anxiety and its disorders: the nature and treatment of anxiety and panic. New York (NY): Guilford; 1988.
42. Rapee RM. Generalized anxiety disorder: a review of clinical features and theoretical concepts. Clin Psychol Rev 1991;11:419-40.
43. Sanderson WC, Barlow DH. A description of patients diagnosed with DSM-III-R generalized anxiety disorder. J Nerv Ment Dis 1990;178:588-91.
44. Brown TA, Chorpita BF, Barlow DH. Structural relationship among dimensions of the DSM-IV anxiety and mood disorders and dimensions of negative affect, positive affect, and autonomic arousal. J Abnorm Psychol 1998;107:179-92.
45. Clark LA, Watson, D. Tripartite model of anxiety and depression: psychometric evidence and taxonomic implications. J Abnorm Psychol 1991;100:316-36.
46. Labrecque J, Dugas MJ, Marchand A, Letarte A. Cognitive-behavioral therapy for comorbid generalized anxiety disorder and panic disorder with agoraphobia. Behavior Modification. Forthcoming.
47. Lydiard RB, Monnier J. Pharmacological treatment. In: Heimberg RG, Turk CL, Mennin DS, editors. Generalized anxiety disorder: Advances in research and practice. New York (NY): Guilford; 2004, p. 351-79.